144 related articles for article (PubMed ID: 6627697)
21. Hypothalamic dopamine may play a role in inducing prolactin in pituitary cells.
Hagino N; Inoue K
Int J Dev Neurosci; 1986; 4(2):119-28. PubMed ID: 3455576
[TBL] [Abstract][Full Text] [Related]
22. Intraventricular administration of histidyl-proline-diketopiperazine [Cyclo(His-Pro)] suppresses prolactin secretion and synthesis: a possible role of Cyclo(His-Pro) as dopamine uptake blocker in rat hypothalamus.
Jikihara H; Ikegami H; Koike K; Wada K; Morishige K; Kurachi H; Hirota K; Miyake A; Tanizawa O
Endocrinology; 1993 Mar; 132(3):953-8. PubMed ID: 7679984
[TBL] [Abstract][Full Text] [Related]
23. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR
J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980
[TBL] [Abstract][Full Text] [Related]
24. Prolactin secretion by metoclopramide in man.
Judd SJ; Lazarus L; Smythe G
J Clin Endocrinol Metab; 1976 Aug; 43(2):313-7. PubMed ID: 7571
[TBL] [Abstract][Full Text] [Related]
25. Initial study on the possible mechanisms involved in the effects of high doses of perfluorooctane sulfonate (PFOS) on prolactin secretion.
Salgado R; Pereiro N; López-Doval S; Lafuente A
Food Chem Toxicol; 2015 Sep; 83():10-6. PubMed ID: 26032630
[TBL] [Abstract][Full Text] [Related]
26. Chlorpromazine, haloperidol, metoclopramide and domperidone release prolactin through dopamine antagonism at low concentrations but paradoxically inhibit prolactin release at high concentrations.
Besser GM; Delitala G; Grossman A; Stubbs WA; Yeo T
Br J Pharmacol; 1980; 71(2):569-73. PubMed ID: 6110459
[TBL] [Abstract][Full Text] [Related]
27. Size heterogeneity of prolactin secreted from and stored in the rat anterior pituitary gland in vitro.
Bentley AM; Surowy TK; Wallis M
Biosci Rep; 1984 Feb; 4(2):129-37. PubMed ID: 6713084
[TBL] [Abstract][Full Text] [Related]
28. Morphine can stimulate prolactin release independent of a dopaminergic mechanism.
Shin SH; Obonsawin MC; Van Vugt DA; Baby N; Jhamandas K
Can J Physiol Pharmacol; 1988 Nov; 66(11):1381-5. PubMed ID: 2907416
[TBL] [Abstract][Full Text] [Related]
29. Dopaminergic and serotonergic involvement in opiate-induced prolactin release in monkeys.
Wehrenberg WB; McNicol D; Wardlaw SL; Frantz AG; Ferin M
Endocrinology; 1981 Aug; 109(2):544-7. PubMed ID: 7250056
[TBL] [Abstract][Full Text] [Related]
30. Effect of reserpine on the inhibition of prolactin released from different pituitary constructs in vitro by dopamine, bromocriptine and apomorphine.
Dutt A; Juneja HS
Endocr Res; 1992; 18(4):307-20. PubMed ID: 1473523
[TBL] [Abstract][Full Text] [Related]
31. Long-term ACTH induced diminished responsiveness of prolactin secretion to morphine.
Kanyicska B; Stark E; Horváth G; Simonyi A; Fekete MI
Life Sci; 1983 Jul; 33(1):55-63. PubMed ID: 6306374
[TBL] [Abstract][Full Text] [Related]
32. Prolactin-releasing peptide and its homolog RFRP-1 act in hypothalamus but not in anterior pituitary gland to stimulate stress hormone secretion.
Samson WK; Keown C; Samson CK; Samson HW; Lane B; Baker JR; Taylor MM
Endocrine; 2003; 20(1-2):59-66. PubMed ID: 12668869
[TBL] [Abstract][Full Text] [Related]
33. Evidence for the involvement of hypothalamic dopamine and thyrotrophin-releasing hormone in suckling-induced release of prolactin.
de Greef WJ; Visser TJ
J Endocrinol; 1981 Nov; 91(2):213-23. PubMed ID: 6795296
[No Abstract] [Full Text] [Related]
34. Prolactin response to buspirone challenge in the presence of dopaminergic blockade.
Maskall DD; Zis AP; Lam RW; Clark CM; Kuan AJ
Biol Psychiatry; 1995 Aug; 38(4):235-9. PubMed ID: 8547445
[TBL] [Abstract][Full Text] [Related]
35. The dopamine agonist, PHNO ((+)-4-propyl-9-hydroxynaphthoxazine), inhibits cyclic adenosine 3',5'-monophosphate formation and prolactin release from anterior pituitary cells.
Login IS; Trugman JM
Neuropharmacology; 1989 Jun; 28(6):647-50. PubMed ID: 2547181
[TBL] [Abstract][Full Text] [Related]
36. Increased prolactin and thyrotrophin secretion following oral metoclopramide: dose-response relationships.
Healy DL; Burger HG
Clin Endocrinol (Oxf); 1977 Sep; 7(3):195-201. PubMed ID: 908151
[TBL] [Abstract][Full Text] [Related]
37. Stimulation and inhibition of prolactin release by prolactin-releasing Peptide in rat anterior pituitary cell aggregates.
Swinnen E; Boussemaere M; Denef C
J Neuroendocrinol; 2005 Jun; 17(6):379-86. PubMed ID: 15929743
[TBL] [Abstract][Full Text] [Related]
38. Role of nitric oxide in control of prolactin release by the adenohypophysis.
Duvilanski BH; Zambruno C; Seilicovich A; Pisera D; Lasaga M; Diaz MC; Belova N; Rettori V; McCann SM
Proc Natl Acad Sci U S A; 1995 Jan; 92(1):170-4. PubMed ID: 7529411
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of increased prolactin secretion by sulpiride.
MacLeod RM; Robyn C
J Endocrinol; 1977 Mar; 72(3):273-7. PubMed ID: 853259
[TBL] [Abstract][Full Text] [Related]
40. An inhibitory role for morphine on the release of dopamine into hypophysial portal blood and on the synthesis of dopamine in tuberoinfundibular neurons.
Reymond MJ; Kaur C; Porter JC
Brain Res; 1983 Mar; 262(2):253-8. PubMed ID: 6404502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
